Learnings from the latest PCSK9i results and profiles of patients who may benefit the most: post- ACS patients with elevated atherogenic lipid levels
Depression predicts mortality 7 years post implant in patients with an implantable cardioverter defibrillator
Identifying patients who may benefit most from PCSK9i: highlights from the latest ODYSSEY OUTCOMES data
Dual antiplatelet therapy and PCI - Important controversies
Comparison of quality of life of patients with a subcutaneous implantable defibrillator and patients with a transvenous system 12 months post implant: a matched cohort study
Evaluation of arterial baroreflex sensitivity in subjects with postural tachycardia syndrome
Interconnection the characteristics of orthostatic resistance and arterial baroreflex sensitivity in patients with postural tachycardia syndrome.
Keywords: implantable cardioverter-defibrillator, lifestyle, physical activity, sudden cardiac death, ventricular arrhythmias Introduction Approximately 50% of cardiac arrests occur in individuals ...
Atrial fibrillation during chemotherapy - Assessing the risk-benefit ratio for anticoagulation